OBJECTIVE: The purpose of this study was 1) to determine the prevalence of functional bowel and @entity74 as defined by the Rome II criteria in @entity1 with advanced @entity3577 ( @entity3577 ) and @entity322 ( @entity322 ), and (2) to determine if the extent of prolapse on gynecologic examination is related to the subtypes of @entity1142 or any functional @entity2531 . STUDY DESIGN: Three hundred and two consecutive female subjects presenting to a tertiary urogynecology clinic were enrolled. Demographic, general medical, and physical examination information, including POPQ measurements and a standardized sacral neurologic evaluation, were collected. The prevalence of functional disorders of the bowel, rectum, and anus as defined by the Rome II criteria were collected using the Rome II Modular questionnaire. @entity2383 to various components of the vaginal examination were reviewed. RESULTS: Thirty-six percent (108/302) met the criteria for @entity1142 , including the following subtypes: 19% outlet @entity1142 , 5% functional @entity1142 , 5% @entity1142 predominant @entity1744 ( @entity1744 ), and 7% @entity1744 -outlet. Nineteen percent (56/302) of subjects had @entity1744 or 1 of its subtypes. Functional @entity294 was seen in 6% (17/302), @entity1241 in 19% (58/302), and @entity2531 in 25% (77/302). After controlling for age, parity, @entity6 , constipating medications, and previous pelvic surgery, there were no differences in the prevalence of @entity1142 or any of its subtypes between @entity1 with @entity322 and those with stage 3 or 4 @entity3577 . @entity1241 was independently associated with @entity322 (adjusted odds ratio [OR] 6.3; 95% CI 2.6-19.1), but not advanced @entity3577 . Neither overall stage of @entity3577 nor stage of posterior vaginal prolapse was significantly associated with any of the functional @entity29 , including @entity1142 and its subtypes. Perineal body measurement was significantly longer in @entity1 with outlet type @entity1142 (mean 3.5 +/- 0.6 cm vs 3.1 +/- 0.9 cm, P < .01) and in those with @entity18252 fugax (mean 3.4 +/- 1.0 vs 3.1 +/- 0.8, P < .05). CONCLUSION: There is a high prevalence of @entity1142 and @entity2531 in @entity1 with @entity322 and @entity3577 . However, @entity1 with stage 3 or 4 @entity3577 have similar rates of @entity1142 compared with those with @entity322 . Constipation and its subtypes are not related to the stage of @entity3577 . It appears that either @entity1142 is not a significant contributor to prolapse, or @entity1142 contributes equally to the development of both @entity322 and @entity3577 .

Functional bowel and @entity74 in @entity1 with @entity3577 and XXXX .

@entity1 :: ('9606', 'Species') :: ['women', 'patients'] @entity322 :: ('MESH:D014549', 'Disease') :: ['urinary incontinence', 'UI'] @entity6 :: ('MESH:D003920', 'Disease') :: ['diabetes'] @entity294 :: ('MESH:D003967', 'Disease') :: ['diarrhea'] @entity29 :: ('MESH:D015212', 'Disease') :: ['bowel disorders'] @entity1744 :: ('MESH:D043183', 'Disease') :: ['irritable bowel syndrome', 'IBS'] @entity74 :: ('MESH:D030342', 'Disease') :: ['anorectal disorders'] @entity2531 :: ('MESH:D013001', 'Disease') :: ['anorectal pain disorder', 'anorectal pain disorders'] @entity18252 :: ('MESH:C566287', 'Disease') :: ['proctalgia'] @entity1241 :: ('MESH:D005242', 'Disease') :: ['Fecal incontinence', 'fecal incontinence'] @entity1142 :: ('MESH:D003248', 'Disease') :: ['constipation'] @entity3577 :: ('MESH:D056887', 'Disease') :: ['pelvic organ prolapse', 'POP'] @entity2383 :: ('MESH:D028361', 'Disease') :: ['Relationships of functional disorders']
@entity322 :: (MESH:D014549,Disease) :: ['incontinence']
